Stroke constitutes the primary source of adult functional disability, exhibiting a paramount
socioeconomic burden. Thus, it is of great importance that the prediction of stroke outcome …

Biomarkers are objectively measured biological properties of normal and pathological
processes. Early neurological deterioration (END) refers to the deterioration of neurological …

Background and Purpose: Outcome prognostication in ischemic stroke patients remains
challenging due to limited predictive properties of existing models. Blood-based biomarkers …

Background and Purpose—The performance of validated prognostic clinical models in acute
ischemic stroke might be improved by addition of data on blood biomarkers. Methods—We …

Background Correct diagnosis of stroke and its subtypes is pivotal in early stages for
optimum treatment. Aims The aim of this systematic review and meta-analysis is to …

Blood biomarkers are increasingly beginning to play a role in the diagnosis, management,
and prognostication of patients with acute ischemic stroke. While imaging biomarkers have …

Background and objective: Prediction of poststroke recovery can be expressed by
prognostic biomarkers that are related to the pathophysiology of stroke at the cellular and …

Blood biomarkers may have applications in stroke diagnosis, outcome prediction, or
treatment. In this article, we provide a focused review on some of the methodological …

Stroke, a complex and heterogeneous disease, is a leading cause of morbidity and mortality
worldwide. The timely therapeutic intervention significantly impacts patient outcomes, but …

Biomarkers provide critical mechanistic insights to key biologic processes that occur during
cerebral ischemia which, when carefully applied, can improve clinical decision-making in …